Eli Lilly and Co., US5324571083

Lam Research stock falls after UBS cuts target and valuation concerns rise

Published on 09/02/2026 at 06:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lam Research stock is under pressure as investors digest a UBS price-target cut and fresh valuation metrics that show the semiconductor equipment maker trading far above some fair-value estimates.

Bauhaus-Poster mit geometrischen Formen und dem Wort PHARMA in Rot und Blau
Bauhaus-Poster mit geometrischen Formen repräsentiert Eli Lilly and Company, ISIN US5324571083, im Pharmasektor gestalterisch, Illustration mit AI erstellt.

Lam Research stock (ISIN US5324571083) came under renewed pressure as of September 1, 2026, with the share price trading around 290.20 USD after a decline of about 3.7 percent according to market data compiled by GuruFocus.

UBS trims target, valuation flashes warning

According to an update reported by GuruFocus on September 1, 2026, UBS has maintained its rating on Lam Research but lowered its price target for the stock to 425 USD.

The same GuruFocus analysis notes that Lam Research has a GF Value estimate of 150.71 USD, implying the stock is about 94.5 percent overvalued at a current price of 293.18 USD as referenced in the report.

Recent share performance and market context

A separate market commentary from GuruFocus on September 1, 2026 states that Lam Research shares fell 3.7 percent to 290.20 USD, highlighting a GF Score of 85 that combines profitability, growth, and financial strength metrics.

In intraday trading referenced by Benzinga on September 1, 2026, Lam Research shares were down about 3.95 percent at 289.57 USD, with the article citing the UBS target cut, an insider sale and rising yields as negative influences.

Go deeper

More Lam Research stock coverage

Further news, price data and regulatory filings for Lam Research can be found in the dedicated topic overview.

Etch and deposition tools as a core product

Lam Research focuses on wafer fabrication equipment, particularly advanced etch and deposition systems used in the manufacture of logic and memory chips.

Stock price snapshot and investor view

As of September 1, 2026, Lam Research stock was quoted around 290.20 USD on its US listing, reflecting the recent pullback after the UBS price-target reduction and ongoing valuation debates among investors.

Lam Research stock facts

  • Company: Lam Research Corporation
  • ISIN: US5324571083
  • Ticker: LRCX
  • Trading venue: NASDAQ
  • Price (as of September 1, 2026): 290.20 USD
  • Sector / Industry: Semiconductors / Semiconductor equipment
  • Index membership: S&P 500

More about Lam Research

Disclaimer...

en | US5324571083 | ELI LILLY AND CO. | boerse | 70041013 | bgmi